BrightPath Biotherapeutics Co Ltd 4594.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
188.00quote price arrow down-4.00 (-2.08%)
Volume
497,300
52 week range
170.00 - 356.00

...

Loading . . .

KEY STATS

  • Open191.00
  • Day High191.00
  • Day Low183.00
  • Prev Close192.00
  • 52 Week High356.00
  • 52 Week High Date06/29/20
  • 52 Week Low170.00
  • 52 Week Low Date03/13/20
  • Market Cap92.07M
  • Shares Out49.72M
  • 10 Day Average Volume325,910
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-27.41

RATIOS/PROFITABILITY

  • EPS (TTM)-38.00
  • P/E (TTM)-4.95
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BrightPath Biotherapeutics Co Ltd News

There is no recent news for this security.

Latest 4594.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
BrightPath Biotherapeutics Co., Ltd. is a Japan-based company mainly engaged in the development of pharmaceutical products. The Company is a biopharmaceutical venture company focused on developing cancer immunotherapeutic. The Companies business model covers drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, manufacturing, and launching of the drugs as commercial products in Japan and...
Kenichi Nagai
President
Yutaka Waki
Chief Operating Officer
Address
Chiyoda-ku, TKY
102-0083
Japan